myeloid malignancies
Showing 1 - 11 of 11
Myeloid Malignancies Trial in Chendu (fractionated busulfan-based conditioning regimen)
Recruiting
- Myeloid Malignancies
- fractionated busulfan-based conditioning regimen
-
Chendu, Sichuan, ChinaWest China Hospital, Sichuan University
Mar 29, 2023
Acute Myeloid Leukemia, MDS, Myeloid Malignancies Trial in Boston (Decitabine, Filgrastim)
Not yet recruiting
- Acute Myeloid Leukemia
- +6 more
-
Boston, Massachusetts
- +1 more
Mar 31, 2023
Myeloid Malignancies Trial in Italy (GvHD prophylaxis)
Recruiting
- Myeloid Malignancies
- GvHD prophylaxis
-
Alessandria, Italy
- +32 more
Nov 23, 2022
Myeloid Malignancies, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Houston (Cyclophosphamide, Mesna, Filgrastim)
Recruiting
- Myeloid Malignancies
- +3 more
- Cyclophosphamide
- +7 more
-
Houston, TexasM D Anderson Caner Center
Nov 17, 2022
Myeloid Malignancies Trial in Australia, United Kingdom, United States (Magrolimab, Azacitidine, Venetoclax)
Recruiting
- Myeloid Malignancies
- Magrolimab
- +6 more
-
Birmingham, Alabama
- +12 more
Apr 6, 2022
Myeloid Malignancies, Lymphoid Malignancies Trial in Durham (NK Cell enriched-DLI only, NK-DLI + DUK-CPG-001)
Recruiting
- Myeloid Malignancies
- Lymphoid Malignancies
- NK Cell enriched-DLI only
- NK-DLI + DUK-CPG-001
-
Durham, North CarolinaDuke University Health System
Mar 8, 2022
Myeloid Malignancies, Acute Myelogenous Leukemia, Chronic Myelogenous Leukemia Trial in Hackensack (Fludarabine and Busulfan
Active, not recruiting
- Myeloid Malignancies
- +4 more
- Fludarabine and Busulfan plus/minus Total Body Irradiation (low dose)
- Fludarabine and Busulfan + Low Dose Total Body Irradiation (LD TBI)
-
Hackensack, New JerseyJohn Theurer Cancer Center at Hackensack University Medical Cent
Feb 25, 2022
Primary Myelofibrosis, Secondary Myelofibrosis, Myeloid Malignancies Trial in Rochester (Imetelstat)
Completed
- Primary Myelofibrosis
- +2 more
-
Rochester, Minnesota(unnamed)
Aug 24, 2021
Myeloid Malignancies Trial in Chongqing (Anti-CD33-CAR-transduced T cells)
Unknown status
- Myeloid Malignancies
- Anti-CD33-CAR-transduced T cells
-
Chongqing, Chongqing, ChinaSouthwest Hospital of Third Millitary Medical University
Jun 23, 2019
Myeloid Malignancies Trial in Chongqing (Anti-LeY-CAR-transduced T cells)
Unknown status
- Myeloid Malignancies
- Anti-LeY-CAR-transduced T cells
-
Chongqing, Chongqing, ChinaSouthwest Hospital of Third Millitary Medical University
Jan 20, 2018